Cell differentiation and proliferation - Simultaneous but independent?

Experimental Cell Research

Volumn 291, Issue 2, 2003, Pages 282-288

  Brown, Geoffrey ^a   Hughes, Philip J ^a   Michell, Robert H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DESMOSOME; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; QUESTIONNAIRE; SHORT SURVEY;

EID: 0344010196     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00393-8     Document Type: Short Survey

References (71)

1. Sachs L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia a model for the origin and progression of malignancy . Proc. Natl. Acad. Sci. USA. 77:1980;6152-6156.
2. Maione R., Amati P. Interdependence between muscle differentiation and cell-cycle control. Biochim, Biophys. Acta. 1332:1997;M19-M30.
3. Walsh K., Perlman H. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7:1997;597-602.
4. Gurdon J.B., Fairman S. Muscle gene activation by induction and the nonrequirement for cell division. J. Embryol. Exp. Morphol. 97:(Suppl.):1986;75- 84.
5. Conlon I., Raff M. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J. Biol. 2:2003;7.
6. Coelho C.M., Leevers S.J. Do growth and cell division rates determine cell size in multicellular organisms? J. Cell Sci. 113:2000;2927-2934.
7. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
8. Lees E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:1995;773-780.
9. Marx J. Cell biology. Cell cycle inhibitors may help brake growth as cells develop. Science. 267:1995;963-964.
10. Hunter T., Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
11. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
12. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
13. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862.
14. Matushansky I., Radparvar F., Skoultchi A.I. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors. Blood. 96:2000;2755-2764.
15. Liu M., Lee M.H., Cohen M., Bommakanti M., Freedman L.P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
16. Bergh G., Telleus A., Fritzon A., Komfalt S., Johnson E., Olsson I., Gullberg U. Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation. Exp. Hematol. 29:2001;1382-1391.
17. Hengst L., Reed S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science. 271:1996;1861-1864.
18. Steinman R.A., Huang J., Yaroslavskiy B., Goff J.P., Ball E.D., Nguyen A. Regulation of p21(WAF1) expression during normal myeloid differentiation. Blood. 91:1998;4531-4542.
19. Campbell M.J., Drayson M.T., Durham J., Wallington L., Siu-Caldera M.L., Reddy G.S., Brown G. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation. Mol. Cell. Endocrinol. 149:1999;169-183.
20. Yen A., Williams M., Platko J.D., Der C., Hisaka M. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur. J. Cell Biol. 65:1994;103-113.
21. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
22. Brugarolas J., Chandrasekaran C., Gordon J.L., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:1995;552-557.
23. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
24. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushansky K., Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:1996;733-744.
25. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
26. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
27. McLeod D.L., Shreeve M.M., Axelrad A.A. Improved plasma culture system for production of erythrocytic colonies in vitro quantitative assay method for CFU-E . Blood. 44:1974;517-534.
28. Rots N.Y., Liu M., Anderson E.C., Freedman L.P. A differential screen for ligand-regulated genes identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells . Mol. Cell. Biol. 18:1998;1911-1918.
29. Beug H., Mullner E.W., Hayman M.J. Insights into erythroid differentiation obtained from studies on avian erythroblastosis virus. Curr. Opin. Cell Biol. 6:1994;816-824.
30. Brown G., Choudhry M.A., Durham J., Drayson M.T., Michell R.H. Monocytically differentiating HL60 cells proliferate rapidly before they mature. Exp. Cell Res. 253:1999;511-518.
31. Rots N.Y., Iavarone A., Bromleigh V., Freedman L.P. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood. 93:1999;2721-2729.
32. Liu Q., Ning W., Dantzer R., Freund G.G., Kelley K.W. Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J. Immunol. 160:1998;1393-1401.
33. Juan G., Traganos F., Darzynkiewicz Z. Histone H3 phosphorylation in human monocytes and during HL-60 cell differentiation. Exp. Cell Res. 246:1999;212-220.
34. Chen F., Studzinski G.P. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Exp. Cell Res. 249:1999;422-428.
35. Wang X., Rao J., Studzinski G.P. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells. Exp. Cell Res. 258:2000;425-437.
36. Liu Q., VanHoy R.W., Zhou J.H., Dantzer R., Freund G.G., Kelley K.W. Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages. Mol. Cell. Biol. 19:1999;6229-6239.
37. Drayson M.T., Michell R.H., Durham J., Brown G. Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid. Exp. Cell Res. 266:2001;126-134.
38. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E.S., Golub T.R. Interpreting patterns of gene expression with self-organizing maps methods and application to hematopoietic differentiation . Proc. Natl. Acad. Sci. USA. 96:1999;2907-2912.
39. Liu T.X., Zhang J.W., Tao J., Zhang R.B., Zhang Q.H., Zhao C.J., Tong J.H., Lanotte M., Waxman S., Chen S.J., Mao M., Hu G.X., Zhu L., Chen Z. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood. 96:2000;1496-1504.
40. Brown G., Drayson M.T., Durham J., Toellner K.M., Hughes P.J., Choudhry M.A., Taylor D.R., Bird R., Michell R.H. HL60 cells halted in G1 or S phase differentiate normally. Exp. Cell Res. 281:2002;28-38.
41. Studzinski G.P., Bhandal A.K., Brelvi Z.S. Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25- dihydroxyvitamin D3. Cancer Res. 45:1985;3898-3905.
42. Li Y.M., Schacher D.H., Liu Q., Arkins S., Rebeiz N., McCusker R.H. Jr., Dantzer R., Kelley K.W. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology. 138:1997;362-368.
43. Wang X., Studzinski G.P. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J. Cell Biochem. 80:2001;471-482.
44. Valentinis B., Navarro M., Zanocco-Marani T., Edmonds P., McCormick J., Morrione A., Sacchi A., Romano G., Reiss K., Baserga R. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J. Biol. Chem. 275:2000;25451-25459.
45. Valentinis B., Romano G., Peruzzi F., Morrione A., Prisco M., Soddu S., Cristofanelli B., Sacchi A., Baserga R. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J. Biol. Chem. 274:1999;12423-12430.
46. Valentinis B., Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54:2001;133-137.
47. Jin S., Zhai B., Qiu Z., Wu J., Lane M.D., Liao K. c-Crk, a substrate of the insulin-like growth factor-1 receptor tyrosine kinase, functions as an early signal mediator in the adipocyte differentiation process. J. Biol. Chem. 275:2000;34344-34352.
48. Qiu Z., Wei Y., Chen N., Jiang M., Wu J., Liao K. DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes. J. Biol. Chem. 276:2001;11988-11995.
49. Liao K., Lane M.D. The blockade of preadipocyte differentiation by protein-tyrosine phosphatase HA2 is reversed by vanadate. J. Biol. Chem. 270:1995;12123-12132.
50. MacDougald O.A., Lane M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:1995;345-373.
51. Gasser S.M. Visualizing chromatin dynamics in interphase nuclei. Science. 296:2002;1412-1416.
52. Greaves M.F., Delia D., Robinson J., Sutherland R., Newman R. Exploitation of monoclonal antibodies a "who's who" of haemopoietic malignancy . Blood Cells. 7:1981;257-280.
53. van Leeuwen J.E., Samelson L.E. T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11:1999;242-248.
54. van Oers N.S. T cell receptor-mediated signs and signals governing T cell development. Semin. Immunol. 11:1999;227-237.
55. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nature Immunol. 2:2001;423-429.
56. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:1998;229-237.
57. Gett A.V., Hodgkin P.D. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA. 95:1998;9488-9493.
58. Richter A., Lohning M., Radbruch A. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J. Exp. Med. 190:1999;1439-1450.
59. Ben-Sasson S.Z., Gerstel R., Hu-Li J., Paul W.E. Cell division is not a "clock" measuring acquisition of competence to produce IFN-gamma or IL-4. J. Immunol. 166:2001;112-120.
60. Laouar Y., Crispe I.N. Functional flexibility in T cells independent regulation of CD4+ T cell proliferation and effector function in vivo . Immunity. 13:2000;291-301.
61. Lea N.C., Orr S.J., Stoeber K., Williams G.H., Lam E.W., Ibrahim M.A., Mufti G.J., Thomas N.S. Commitment point during G0 - >G1 that controls entry into the cell cycle. Mol. Cell. Biol. 23:2003;2351-2361.
62. Parker D.C. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:1993;331-360.
63. Hodgkin P.D., Lee J.H., Lyons A.B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184:1996;277-281.
64. Dunnick W., Wilson M., Stavnezer J. Mutations, duplication, and deletion of recombined switch regions suggest a role for DNA replication in the immunoglobulin heavy-chain switch. Mol. Cell. Biol. 9:1989;1850-1856.
65. Dunnick W., Stavnezer J. Copy choice mechanism of immunoglobulin heavy-chain switch recombination. Mol. Cell. Biol. 10:1990;397-400.
66. Lundgren M., Strom L., Bergquist L.O., Skog S., Heiden T., Stavnezer J., Severinson E. Cell cycle regulation of immunoglobulin class switch recombination and germ-line transcription potential role of Ets family members . Eur. J. Immunol. 25:1995;2042-2051.
67. van der Loo W., Gronowicz E.S., Strober S., Herzenberg L.A. Cell differentiation in the presence of cytochalasin B studies on the "switch" to IgG secretion after polyclonal B cell activation . J. Immunol. 122:1979;1203-1208.
68. Kenter A.L., Watson J.V. Cell cycle kinetics model of LPS-stimulated spleen cells correlates switch region rearrangements with S phase. J. Immunol. Methods. 97:1987;111-117.
69. Deenick E.K., Hasbold J., Hodgkin P.D. Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J. Immunol. 163:1999;4707-4714.
70. Hasbold J., Gett A.V., Rush J.S., Deenick E., Avery D., Jun J., Hodgkin P.D. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol. 77:1999;516-522.
71. Rush J.S., Hasbold J., Hodgkin P.D. Cross-linking surface Ig delays CD40 ligand-and IL-4-induced B cell Ig class switching and reveals evidence for independent regulation of B cell proliferation and differentiation. J. Immunol. 168:2002;2676-2682.